cause of death to be developed. With respect to cancer, the major mechanism through which smoking exerts its effects, benzo[a] pyrene mediated mutagenesis, on disease pathogenesis is well established (Pfeifer, 2016) . However, for other complex disorders, the degree of our understanding through which smoking exerts its effects varies.
To better understand how smoking exerts its effects on each of these outcomes, a number of investigators have published genome wide analyses of the relationship of cigarette consumption to DNA methylation in peripheral white blood cells (WBC) (Joubert et al., 2012; Monick et al., 2012; Shenker et al., 2012; Zeilinger et al., 2013) . These studies have advanced our understanding of disease pathogenesis. For example, for stroke, the prominent changes in the methylation signatures of clotting factors associated with smoking coupled with prior observations that smoking increases the activity of clotting factors in the serum provides a very plausible rationale to explain the twofold increase risk for stroke conveyed by smoking (Breitling, Salzmann, Rothenbacher, Burwinkel, & Brenner, 2012; Dogan et al., 2014; Wannamethee et al., 2005 ). Yet for other disorders, such as ectopic pregnancy (Bouyer et al., 2003) and a host of psychiatric disorders (Aubin, Rollema, Svensson, & Winterer, 2012; Bouyer et al., 2003; Isensee, Wittchen, Stein, Hofler, & Lieb, 2003; Kendler, Lönn, Sundquist, & Sundquist, 2015; Moylan, Jacka, Pasco, & Berk, 2013) , these genome wide studies have been less illuminating with the result that the connection between smoking and increased risk for many other disorder is not well understood.
There is reason to believe that part of this failure of methylation approaches to explain the effects of smoking on disease risk may be secondary to the presence of confounding interaction effects involving genetic variation with methylation. An initial indication of the existence of such effects was our finding that the degree of smoking induced differential methylation at the most highly ranked methylation probes is strongly influenced by ethnicity, which in this instance is presumably ethnic specific genetic variation Smith et al., 2014) . In a series of earlier publications that examined the effect of smoking on DNA methylation at Monoamine Oxidase A (MAOA), for example, we found that genotype at the well-characterized promoter associated variable nucleotide repeat (VNTR) had a strong effect on DNA methylation across both of the promoter associated CpG islands, resulting in smoking contextual genetic effects on methylation (SNP*Smoke) (Philibert et al., 2010; Philibert, Gunter, Beach, Brody, & Madan, 2008) . Subsequently, several genome wide methylation analyses that included some degree of genetic information have noted SNP*Smoke effects Tsaprouni et al., 2014) .
However, to date, no studies have attempted to quantify the magnitude of those effects of smoking at the genome wide level.
The lack of attempts to conduct SNP*Smoke analyses to better explicate the impact of smoking on genome wide methylation results from two primary obstacles. First, in contrast to straightforward genome wide methylation analyses that can be conducted on a desktop computer, analyses of genetically contextual methylation effects typically require high performance computing environments that may be less readily available. Second, and perhaps more importantly, these analyses require larger datasets with both genome wide genetic and epigenetic data for each subject, along with reliable data on smoking. Fortunately, over the past several years both of these obstacles have become less daunting.
In this communication, we report an integrated examination of the effects of smoking on DNA methylation in the presence and absence of genetic context using the resources of the largest publically available cohort of subjects with both genome wide genetic and epigenetic data, the Framingham Heart Study (Dawber, Kannel, & Lyell, 1963) .
| METHODS

| Framingham heart study
The data used in this study is derived from participants in the Framingham Heart Study (FHS) (Dawber et al., 1963) . FHS is a population-based longitudinal study aimed at understanding the risks of cardiovascular disease (CVD) and consists of several cohorts including the Original Cohort, Offspring Cohort, Omni Cohort, Third Generation Cohort, New Offspring Spouse Cohort, and Second Generation Omni Cohort (Mahmood, Levy, Vasan, & Wang, 2014 
| Genome wide DNA methylation
Of the 5,124 individuals in the Offspring Cohort, only 2,567 individuals (duplicates removed) with DNA methylation data were considered.
These individuals were included in the DNA methylation study because they attended the Framingham Offspring 8th exam, provided consent for genetic research, had a buffy coat (WBC) sample, and had sufficient DNA quantity and quality for methylation profiling. Exam 8 took place between 2005 and 2008. Genomic DNA extracted from the buffy coat was bisulfite converted and genome wide DNA methylation was profiled using the Illumina HumanMethylation450 BeadChip (San Diego, CA) at either the University of Minnesota or Johns Hopkins University. The intensity data (IDAT) files of the samples alongside their slide and array information were used to perform the DASEN normalization using the MethyLumi, WateRmelon, and IlluminaHumanMethylation450 k.db R packages (Pidsley et al., 2013) . The DASEN normalization performs probe filtering, background correction, and adjustment for probe types. Samples were removed if they contained >1% of CpG sites with a detection p-value >0.05. CpG sites were removed if they had a bead count of <3 and/or >1% of samples had a shown that the effects of smoking on DNA methylation are robust to the effects of cellular heterogeneity (Bauer et al., 2016; Dogan et al., 2014; Joubert et al., 2016) and current mechanism for correction are computationally prohibitive for the current analyses, we have followed the recommendations of Bauer et al. (2016) and not corrected for cellular composition.
| Genome wide genotype
Of the 2,560 remaining individuals after DNA methylation quality control, 2,406 (1,100 males and 1,306 females) had genome wide genotype data from the Affymetrix GeneChip HumanMapping 500 K Array Set (Santa Clara, CA). This array is capable of profiling 500,568
SNPs in the genome. Quality control was performed at both the sample and SNP probe levels in PLINK. (Purcell et al., 2007) The initial quality control step involved identifying individuals with discordant sex information. None were identified. Next, individuals with a heterozygosity rate of greater or smaller than the mean ± 2SD and with a proportion of missing SNPs >0.03 were excluded. Population stratification was performed and no individuals were removed. Related individuals were also excluded if the identity by descent value was >0.185 (approximately halfway between second and third degree relatives). After performing these sample level quality control steps, 1,599 individuals remained (722 males and 877 females). On the probe level, SNPs with a minor allele frequency >1%, Hardy-Weinberg equilibrium p-value >10 −5 and SNP missing rate of <5% were retained.
A total of 403,192 SNPs remained after these quality control steps.
Using the recode option in PLINK, genotypes were coded as 0, 1, or 2.
| Phenotypes
In the analyses, phenotypes that were considered include age, gender, batch, and smoke exposure. 
| Linear regression of genome wide DNA methylation
Our first analysis was to identify smoking associated DNA methylation (CpG) sites. To achieve that, a linear model was fitted in R:
For every CpG site, the methylation was regressed against smoking status (smoke), controlling for age, gender, and batch.
Correction for multiple comparisons was performed using Bonferroni correction. (Fleiss, 1981) A genome wide significance level of 0.05 was used. A total of 484,125 independent tests were conducted.
Therefore, only CpG sites with a nominal p-value of 1e-07 or less (0.05/484125) were considered to be significantly associated with smoking status.
| SNP × Smoke (G × E) interaction
To understand the effect of SNP on methylation given smoking status, the following model was interrogated:
Specifically, the interaction term (SNP j * Smoke) was of interest because it allows the understanding of the interplay between genotype and smoke exposure (environment) on DNA methylation.
A cis distance of 1 Mb was used to distinguish cis-interaction effects (SNP in SNPxSmoke interaction term cis of methylation site) from trans-interaction effects (SNP in SNP × Smoke interaction term trans of methylation site). In the MatrixeQTL package, this was achieved using the modelLINEAR_CROSS model type (Shabalin, 2012) . Correction for multiple comparisons at a 0.05 significance level was performed using the Bonferroni method (Fleiss, 1981) . A total of 126,369,511 cis and 195,068,554,297 trans independent interaction tests were performed, which implies that cis-interactions with a nominal p-value of 3.96e-10 or less (0.05/126369511) and transinteractions with a nominal p-value of 2.60e-13 or less (0.05/ 195068554297) are significant. Genomic inflation factors for each chromosome for cis-interactions and Y chromosome for transinteractions were calculated using the GenABEL R package.
| Protein-protein interaction networks
To better visualize and compare the connectivity and gene ontology (GO) enrichment between significant genes in the regression and interaction analyses, we generated protein-protein interaction (PPI)
networks. To generate these networks, STRING Version 10 was used (Szklarczyk et al., 2010) . This database contains information of known and predicted direct and indirect PPIs. A total of three networks were produced. The first network was for the methylation regression analysis, where the input genes were those that had at least one significant CpG site with respect to smoking status after correction for | 597 multiple comparisons. The second (cis-interaction) network was generated using genes of methylation probes with at least one significant SNP*Smoke interaction effect where the SNP and methylation probe are in cis of each other. Finally, the third (transinteraction) network was generated using genes of methylation probes with at least one significant SNP × Smoke interaction effect where the SNP and methylation probe are in trans of each other.
| Functional SNP mapping
To complement the PPI analysis and obtain a holistic understanding of smoking contextual effects on disease outcomes, we performed an analysis to determine and map functional SNPs. Specifically, the significant cis-and trans-interaction SNPs were used in this analysis.
The freely available, user-friendly SNPnexus functional annotation web server was used (Dayem Ullah, Lemoine, & Chelala, 2012) .
| RESULTS
Epigenetic and genetic data from 1599 subjects were included in this study (Table 1 ). All subjects were of northern European ancestry and tended to be in their early to mid-sixties. The rate of self-reported smoking was 7.6%, which is slightly lower than the national rate of smoking for subjects >65 years of age, and markedly less than the national rate of 21% for those between 45 and 64 years of age (Centers Table 2 while the complete list of 525 sites is given in Supplemental Table S1 . Consistent with prior studies, cg05575921
was the top ranked probe with a p-value <0.001 (7.65 × 10 ) and the 13th ranked probe cg19859270 (GPR15) with a p-value <0.001 (2.9 × 10 −39
). Interestingly, there was a relationship between slope of the regression (i.e., demethylation or hypermethylation) in response to smoking and probe rank. Overall, 386 of the 525 probes (74%) manifested demethylation in response to smoking. All of the top 30 sites shown in Table 2 manifested demethylation in response to smoking. However, as illustrated in Supplementary Table S1 , as probe rank decreased, the likelihood of having a positive slope (i.e., hypermethylation) in response to smoking increased (Wilcoxon rank sum p < 0.0001).
Using the Illumina annotation file, we attempted to map the significant probes to specific genes. A total of 412 CpG of the 525 probes mapped to 310 unique genes. Several genes had at least three or more significant probes mapping to their locus including AHRR (22 probes) and GFL1 (8 probes). The 310 unique genes were subsequently used as the input to generate the first protein-protein interaction (PPI) network.
| SNP × Smoke (G × E) interactions
Based on formula (2) Table 2 , the presence of significant cis-and trans-interactions were examined. None were identified.
None of the calculated genomic inflation factors were greater than one, and therefore, the p-values of interactions were not corrected.
Considering the trans-interactions genomic inflation factors were not calculated for all chromosomes, it is likely that the number of significant loci may decrease. However, it should not affect the most significant loci identified through our analysis. This suggests that smoking does play a role in the reported results.
| Protein-protein interaction (PPI) networks
To identify coherent networks of genes influenced directly by smoking, we examined the potential interconnections of the 310 genes identified in the genome wide methylation analysis using PPI information in the STRING database. A total of 302 of the 310 genes matched with a protein in the database. This network is shown in Table 3 . Of those 141 GO pathways, the largest number of proteins, 124 (41%), was observed in the regulation of metabolic process pathway (GO:0019222) with an FDR p-value of 0.000393.
| Cis-and trans-interaction PPI networks
To obtain a comprehensive understanding on the interplay between genotype, environment and DNA methylation, cis-and trans-interaction networks were generated. Significant cis-interactions were associated with 266 unique genes and mapped to 249
proteins. This network consisted of 249 nodes, 27 edges (20 expected, PPI enrichment p-value = 0.0664) with an average node degree of 0.217. Of these genes, 10 (4%) were also identified in the methylation regression analysis. There were two biological process GO pathways at an FDR of 5%, and are shown in Table 4 . This network is shown in Figure 3 . In this figure, only nodes with edges are shown. Also, only edges with the highest confidence interaction score of 0.9 or larger were retained to focus on patterns of known significance. The colors of the edges represent interaction types and are elaborated in the figure legend.
Due to a large number of trans-interactions, only the genes of the top 1,000 significant interactions were considered. These interactions were associated with 158 unique genes and 148 proteins. Of those, 9
(6%) were also identified in the methylation analysis. The network had 
| DISCUSSION
In summary, we report that when cis and trans effects of genetic variation are considered, smoking has a significant effect on DNA methylation signature of peripheral blood DNA at 4379 genes and that the SNP variation participating in significant interactions preferentially mapping to loci previously associated with complex illness. Still, before considering the current findings it is important to note that FHS cohort is exclusively White and late mid-life. Therefore, further examination of the current findings in subjects of other ethnicities and age groups will be necessary before generalizability of the findings can be accepted. In addition, it should be noted that although both the epigenetic and genetic platforms used herein are considered "genome wide," it is generally appreciated that large portions of both the epigenome and genome are not interrogated by these measures.
The current findings will be particularly useful for those seeking a better understanding of the relationship between smoking and illnesses not classically associated with inflammation. The prominence of inflammatory related genes reported in prior analyses of the effects of smoking on DNA methylation from infants and adults has clearly outlined a plausible molecular explanation for the relationship of smoking to the increased rates of asthma and respiratory tract infections observed in infants and adults (Dogan et al., 2014; Gunawardhana et al., 2014; Zhang, Yang, Burwinkel, Breitling, & Brenner, 2014) . However, these more limited prior findings do not readily explain a connection between smoking and syndromes such as five genes and the effects of smoking on DNA methylation between at least some tissues are correlated, (Novakovic et al., 2013; Teschendorff, Yang, & Wong, 2015) | 603 (Ripke et al., 2014) . Unfortunately, because the area of linkage disequilibrium surrounding many of these SNPs may cover several genes and our network analyses are methylation probe centric, a direct comparison of the genes implicated in our network analyses and those of the Psychiatric Genetics consortium using traditionally associated approaches is not possible. Still, given the wealth of epidemiological data that implicates smoking in the etiology of schizophrenia, (de Leon & Diaz, 2005; Dickerson et al., 2013; Kendler et al., 2015) these data suggest that genetically informed epigenetic analyses of DNA from cohorts informative for schizophrenia may be useful in generating new hypotheses and refining existing hypotheses with respect to the biological underpinnings of psychosis.
Even so, interpretation of the strength of individual interactions should be done with caution for several reasons. First, what matters most for the cell is the amount of protein translation. Unfortunately, the relationship between DNA methylation at a given CpG site with both local and regional gene transcription, and more distally, protein translation, is not well constrained. Second, the number of significant comparisons is dependent on the manner in which the analyses are conducted. Since long range interactions are known to occur, (Smallwood & Ren, 2013) we used a 500,000 bp window on either side of the probe in question in our cis interaction analyses. But the ideal window for these analyses is not known. In prior work, the distance between the CpG site (or probe) and the SNP participating in FIGURE 4 Protein-Protein Interactome (PPI) generated from trans-interaction regression analyses the interactions has been reported to vary from an average of 15 to 1 kb, a discrepancy that is likely secondary to differences in methodology (Shoemaker, Deng, Wang, & Zhang, 2010; Smith et al., 2014) . This uncertainty in the distance between the two partners in the interaction is made even more difficult by the observation that with respect to gene expression, over 20% of all eQTLs exert their effects on non-adjacent gene regions (Li et al., 2016) . As a result of this lack of knowledge of the best window for comparison, the significance of our cis comparisons may be over corrected or under corrected. Third, the SNP that was used in the analyses may not be the polymorphism that is driving the strength of the interaction term. The 403,192 SNPs used in our analyses are merely the tag SNP(s) for a given region that may be in full or partial equilibrium with another polymorphism that is driving SNP*Smoke effects. Should it be necessary to identify the actual variation driving an interaction term, the region will need to be sequenced and carefully controlled experiments similar to those used to identify eQTLs (Albert & Kruglyak, 2015) will need to be conducted.
The current study utilized data from mature adults. However, it is very possible that many of the effects of smoking are also found that over half (52%) of all the 6073 FDR significant probes were hypermethylated in response to maternal smoking which is in direct contrast to the current and prior findings that the vast majority of probes are de-methylated in response to smoking. (Andersen et al., 2015) Although there are a number of possible explanations for the latter discrepancy, it may well be as the number of probes deemed "significantly" affected by smoking increases, the percentage of probes manifesting hypermethylation increases. Our analyses of our lower ranked non-significant probes listed in Supplementary Table S1 supports this hypothesis. Still the differences at key loci such as F2RL3 and GPR15 suggest a differing biological response of in utero fetuses as compared to adolescents and adults to smoking.
The next few steps in the fuller understanding of these findings will be challenging. First, the findings need to be replicated and extended in several ethnically informative populations with good substance use characterization. Although the FHS is one of premier clinical resources in the world, it is not well characterized for substance use and biochemical validation of smoking status was not performed.
Unreliable self-report is a challenge to these analyses of the biology of smoking, particularly in the high-risk populations in which the effects are most evident (Caraballo, Giovino, & Pechacek, 2004; Caraballo, Giovino, Pechacek, & Mowery, 2001; Shipton et al., 2009) . Second, the relationship of individual program methylation to gene transcription needs to be better understood. Unfortunately, the methylation (Illumina 450 K) and gene expression platforms used in the FHS (GeneChip Human Exon 1.0 ST Array) study are already no longer state-of-the-art. In that regard, it probably makes more sense to approach the problem using more up to date methods such whole bisulfitome and RNAseq data that better capture the total methylome and transcriptome, respectively. Third, it is important to note that almost all studies conducted to date, including the current study, use DNA prepared from peripheral white blood cells or saliva. However, for understanding the effect on smoking on vulnerability to nonhematologic disorders, it will be necessary to study biomaterial from the affected tissues, such as the brain, in both humans and model organisms. In that regard, we note the accumulation of high quality biomaterials and data being conducted by the GTEx Consortium, which is conducting integrated genetic, epigenetic, and gene expression studies on fresh post mortem sample from a variety of tissues (Carithers et al., 2015) . Given recent studies showing the strong role of complement activation in the pathogenesis of schizophrenia (Nsaiba et al., 2015; Sekar et al., 2016) and the strong effects of smoking on the methylation of complement cascade genes (Dogan et al., 2014) , it is quite possible that studies of these or similar resources could lead to interventions that could prevent or mitigate the severity of several types of smoking related mental illness.
In summary, we show that integrated genetic and epigenetic analyses demonstrate the profound effects of smoking on methylation status throughout the genome and an enrichment of SNPs with significant smoking contextual methylation effects with those known to be associated with disease. We suggest further integrated analyses could lead to new insights for better prevention and treatment of a variety of smoking related illnesses.
